Larimar Therapeutics, Inc. (LRMR) stock

LRMRNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 6/30

$2.70−0.03 (-1.10%)

Close on Nov 12, 2026Market cap $280.48MP/E –Yield –

Larimar Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

Larimar Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?